CLINICAL_TRIALS
trial_result
· 2020-10-27
Clinical Trial Update: Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis. [Phase 3]
Summary
Phase 3 clinical trial update for ketotifen/naphazoline ophthalmic solution in allergic conjunctivitis; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bausch & Lomb Incorporated | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2020-10-27